FDA Drug Application (022141) for LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE by MATRIX LABS

Back to FDA Applications sponsored by MATRIX LABS

Application Number022141
Product Number001
FormTABLET; ORAL
Dosage300MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by MATRIX LABS